FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 3223517 · Received July 12, 2013

Report

Report Number
2124215-2013-10044
Event Type
Injury
Date Received
July 12, 2013
Date of Event
June 11, 2013
Report Date
July 30, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DISPLAYED A FAULT CODE RELATING TO AN OPEN CIRCUIT WHICH WAS DETECTED DURING SHOCK DELIVERY. THE PATIENT RECEIVED SEVERAL APPROPRIATE SHOCKS. SHOCKING LEAD IMPEDANCE WAS 90 OHMS, RIGHT VENTRICULAR (RV) LEAD PACING IMPEDANCE MEASUREMENT WAS 490 OHMS AND PACING THRESHOLD MEASUREMENTS WERE FINE. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) DISCUSSED THAT THE PATIENT NEEDS TO FOLLOW-UP WITH THE PHYSICIAN BECAUSE BOTH THE DEVICE AND THE LEAD ARE LIKELY TO BE REPLACED. ADDITIONAL INFORMATION WAS OBTAINED INDICATING THAT THE PATIENT IS BEING TREATED WITH CELLULITIS AND AN E.COLI INFECTION WHICH IS NOT RELATED WITH THE PRODUCT. ALSO, THE PATIENT IS WEARING A LIFEVEST AND THE PATIENT IS ON ANTIBIOTICS FOR SEVERAL WEEKS. AFTER THE PATIENT HAS COMPLETED THE ANTIBIOTIC REGIMEN, THE PATIENT WILL BE SCHEDULED FOR A LEAD EXTRACTION AND DEVICE EVALUATION WITH THE PHYSICIAN. THE DEVICE REMAINS IN-SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION INDICATED THAT SURGICAL INTERVENTION WAS PERFORMED FOR REPORTED EVENT. EVEN THOUGH DEVICE WAS NOT EXPLANTED, A NEW LEAD WAS CONNECTED TO THIS DEVICE DUE TO THE ISSUE AND THEREFORE THE OVERALL ISSUE REQUIRED A SURGICAL INTERVENTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
321799 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 38 YR Hospitalization| L| R 0184| E102| 1852